Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma
Seoul National University Hospital
Seoul National University Hospital
UNICANCER
Dana-Farber Cancer Institute
Gachon University Gil Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Alabama at Birmingham
European Lung Cancer Working Party
Peking Union Medical College Hospital
Aktion Bronchialkarzinom e.V.